COVID-19: Playing Defense with Disinfectants
Both work in the same way by breaking down the 3-dimensional structure of the proteins of the bacteria or virus, rendering them useless.
GIOSTAR Reviews Potential Benefits of Stem Cell Therapy on Coronavirus
Since its outbreak, coronavirus (COVID-19) has cast an unprecedented impact that has reverberated throughout the world. Scientists, government officials, and doctors have searched frantically for a remedy, to help contain further disruption. In this video, GIOSTAR Co-Founder and Chairman Dr. Anand Srivastava reports on a study examining [...]
Glutathione: A Closer Look at the “Master Antioxidant”
GIOSTAR Chicago examines glutathione, an extremely powerful antioxidant that helps patients suffering from Parkinson’s disease, diabetes, and numerous other disorders.
GIOSTAR Launches Stem Cell / Cancer Research and Therapy Center in Chandigarh, India
GIOSTAR has played a pivotal role in regenerative medicine in India for many years. This trend continues with the launch of a new stem cell / cancer research and therapy center in Chandigarh, one of the country’s most prestigious cities.
How Do Mesenchymal Stem Cells (MSCs) Reduce Inflammation?
GIOSTAR Chicago reviews in greater detail the potential for mesenchymal stem cells (MSCs) to reduce inflammation. This may provide benefit to patients suffering from multiple sclerosis, rheumatoid arthritis, and other autoimmune disorders.
GIOSTAR Launches Stem Cell Therapy Center in Cancun Riviera
Beyond groundbreaking therapies backed by decades of research, GIOSTAR is a world leader in medical tourism. Learn more about the newest center opening, in the beautiful Cancun Riviera, Mexico.
Data, Data Everywhere: Navigating the Turbulent Waters of Stem Cell Information
Patients can get easily overwhelmed by the plethora of information they come across while exploring stem cell therapy. GIOSTAR Chicago provides a few key considerations for individuals to take into account when researching their options for regenerative medicine.
GIOSTAR In Process of US FDA Approval for Type 2 Diabetes Clinical Trial
For more than two decades, Dr. Anand Srivastava and GIOSTAR have been at the forefront of stem cell therapy and research. The company is currently in process of FDA approval for groundbreaking clinical trials regarding Type 2 Diabetes, which impacts roughly 1 in 10 Americans.
Episode 4: What’s In Your “Healthy Brain Toolbox?” (Part 2)
In the second segment of this 2-part episode, Dr. Gellis continues his discussion on functional medicine with best-selling author, professor, and neurologist Dr. Kenneth Sharlin. Sharlin dives deeper into “The 5 R’s of nutrition,” neuroplasticity, oxidative stress, and numerous other topics covered in his best selling book The Healthy Brain Toolbox, as well as the groundbreaking Brain Tune Up! program.
